Mineyo Mito

Phase 2 study of first‐line pembrolizumab monotherapy in elderly patients with non‐small‐cell lung cancer expressing high PD‐L1

N. Hattori, M. Yamasaki, T. Masuda, 2022, Thoracic cancer.

Pembrolizumab‐caused polyradiculoneuropathy as an immune‐related adverse event

Hideki Yamamoto, T. Kurashige, K. Kuraoka, 2021, Neuropathology : official journal of the Japanese Society of Neuropathology.

Systemic Inflammatory Score Predicts Response and Prognosis in Patients With Lung Cancer Treated With Immunotherapy

A. Ishikawa, K. Taniyama, K. Kuraoka, 2021, AntiCancer Research.

A Case of Spontaneous Regression of Small-cell Lung Cancer with Paraneoplastic Cerebellar Degeneration

T. Kurashige, K. Kuraoka, T. Mimura, 2021, Haigan.

Low lung diffusing capacity is associated with high cardio-ankle vascular index in patients with chronic obstructive pulmonary disease

Yoshihiro Kitahara, K. Nakano, Mineyo Mito, 2021 .

Phase 2 study of first-line pembrolizumab in elderly patients with non-small cell lung cancer expressing high PD-L1.

N. Hattori, M. Yamasaki, T. Masuda, 2022, Journal of Clinical Oncology.

Invasive Mucinous Adenocarcinoma with Acute Respiratory Distress Syndrome Diagnosed by Autopsy Findings

K. Kuraoka, Junichi Zaitsu, Tadashi Senoo, 2022, Internal medicine.

Development of the Japanese version of an information aid to provide accurate information on prognosis to patients with advanced non–small-cell lung cancer receiving chemotherapy: a pilot study

Yoshihiro Kitahara, S. Sunada, K. Nakano, 2018, BMC Palliative Care.